|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 401/04 | (2006.01) |
| C07D 401/04 | (2013.01) | ||
| A61K 31/4545 | (2006.01) |
| (11) | Number of the document | 3853217 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19862150.0 |
| Date of filing the European patent application | 2019-09-18 | |
| (97) | Date of publication of the European application | 2021-07-28 |
| (45) | Date of publication and mention of the grant of the patent | 2023-06-07 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/CN2019/106433 |
| Date | 2019-09-18 |
| (87) | Number | WO 2020/057549 |
| Date | 2020-03-26 |
| (30) | Number | Date | Country code |
| 201862732994 P | 2018-09-18 | US |
| (72) |
CHEN, Xiangyang , CN
WANG, Zuopeng , CN
YU, Liqin , CN
|
| (73) |
Beijing InnoCare Pharma Tech Co., Ltd. ,
Bldg. 8, Community No. 1
No. 8 Courtyard, Life Park Road
ZGC Life Science Park
Changping District, Beijing 102206,
CN
|
| (54) | CRYSTALLINE FORM OF 6-(1-ACRYLOYLPIPERIDIN-4-YL)-2-(4-PHENOXYPHENYL) NICOTINAMIDE |
| CRYSTALLINE FORM OF 6-(1-ACRYLOYLPIPERIDIN-4-YL)-2-(4-PHENOXYPHENYL) NICOTINAMIDE |